Highlights of the new recommendations for hypercholesterolemia.
The patient who benefits most by aggressive efforts to reduce elevated LDL cholesterol is the one who is at greatest risk for a coronary event in the next 5 to 10 years. Thus, treatment decisions are based on risk-factor analysis and personal history.